☰

Sheila Rao, Ph.D. - Publications

Affiliations: 
2013 Immunology University of Pennsylvania, Philadelphia, PA, United States 
Area:
Immunology
Tree Info Grants Similar researchers PubMed Report error

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Biswas C, Rao S, Slade K, Hyman D, Dersh D, Mantegazza AR, Zoltick PW, Marks MS, Argon Y, Behrens EM. Tyrosine 870 of TLR9 is critical for receptor maturation rather than phosphorylation-dependent ligand-induced signaling. Plos One. 13: e0200913. PMID 30024926 DOI: 10.1371/Journal.Pone.0200913  0.309
2015 Rood JE, Rao S, Paessler M, Kreiger PA, Chu N, Stelekati E, Wherry EJ, Behrens EM. ST2 contributes to T cell hyperactivation and fatal hemophagocytic lymphohistiocytosis in mice. Blood. PMID 26518437 DOI: 10.1182/Blood-2015-07-659813  0.561
2013 Rao S, Liu X, Freedman BD, Behrens EM. Spleen tyrosine kinase (Syk)-dependent calcium signals mediate efficient CpG-induced exocytosis of tumor necrosis factor α (TNFα) in innate immune cells. The Journal of Biological Chemistry. 288: 12448-58. PMID 23515313 DOI: 10.1074/Jbc.M113.454405  0.429
2012 Canna S, Slade K, Paessler M, Kreiger P, Rao S, Behrens EM. IL-10 is a critical negative regulator of macrophage activation syndrome Pediatric Rheumatology. 10: 1-1. DOI: 10.1186/1546-0096-10-S1-A110  0.532
2011 Behrens EM, Canna SW, Slade K, Rao S, Kreiger PA, Paessler M, Kambayashi T, Koretzky GA. Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice. The Journal of Clinical Investigation. 121: 2264-77. PMID 21576823 DOI: 10.1172/Jci43157  0.352
2007 Lundqvist A, Rao S, Berg M, Smith A, Su S, Yokoyama H, Srivastava S, Childs R. The Proteasome Inhibitor Bortezomib Simultaneously Enhances NK Cell Tumor Cytotoxicity While Paradoxically Reducing Antigen Specific T-Cell Tumor Cytotoxicity. Blood. 110: 1789-1789. DOI: 10.1182/Blood.V110.11.1789.1789  0.32
Show low-probability matches.